Table 3.
Compounds | Treatment | |||||
---|---|---|---|---|---|---|
Pre-treatment | Co-treatment | Post-treatment | ||||
Lesion diameter (mm) | Disease control (%) | Lesion diameter (mm) | Disease control (%) | Lesion diameter (mm) | Disease control (%) | |
DMSO | 12.933 a (± 0.132) | 13.132 a (± 0.132) | 12.960 a (± 0.099) | |||
Penthiopyrad | 4.167 b (± 0.083) | 67.803 | 4.848 bc (± 0.119) | 63.082 | 5.783 b (± 0.111) | 55.37 |
C1 | 2.543 c (± 0.111) | 80.337 | 3.381 de (± 0.076) | 74.253 | 3.895 d (± 0.16) | 69.945 |
C2 | 2.383 c (± 0.148) | 81.574 | 3.542 d (± 0.0716) | 73.027 | 3.841 d (± 0.115) | 70.362 |
C3 | 3.907 b (± 0.137) | 69.79 | 4.221 c (± 0.1845) | 67.857 | 5.176 bc (± 0.147) | 60.061 |
C4 | 4.002 b (± 0.154) | 69.055 | 4.63 bc (± 0.156) | 64.742 | 5.627 bc (± 0.095) | 56.581 |
C5 | 3.924 b (± 0.123) | 69.659 | 4.909 b (± 0.182) | 62.618 | 5.2433 bc (± 0.221) | 59.544 |
C6 | 2.210 c (± 0.177) | 82.911 | 2.818 e (± 0.089) | 78.540 | 3.585 d (± 0.098) | 72.337 |
C7 | 3.718 b (± 0.172) | 71.125 | 4.356 bc (± 0.124) | 66.829 | 5.437 bc (± 0.126) | 58.047 |
C8 | 3.976 b (± 0.131) | 69.256 | 4.698 bc (± 0.154) | 64.224 | 5.295 bc (± 0.145) | 59.143 |
C9 | 4.172 b (± 0.178) | 67.414 | 4.549 bc (± 0.144) | 65.359 | 5.026 c (± 0.111) | 61.219 |
C10 | 2.579 c (± 0.102) | 80.058 | 3.059 de (± 0.074) | 76.705 | 3.776 d (± 0.135) | 70.864 |
C11 | 3.685 b (± 0.134) | 71.506 | 4.701 bc (± 0.099) | 64.201 | 5.246 bc (± 0.121) | 59.521 |
C12 | 3.878 b (± 0.136) | 70.014 | 4.971 b (± 0.159) | 62.145 | 5.495 bc (± 0.131) | 57.6 |
Values in parentheses indicate standard error. Means sharing the same letters are not significantly different (P < 0.05; LSD, Statistix 8.1).